Down |
1. | Renin-angiotensin-aldosterone system |
2. | Side effects include worst headache from a medication, drop in BP, and decreased oxygen need of heart; used for angina |
3. | Thickened and stiffened arterial walls; often comorbid with or caused by atherosclerotic changes |
4. | Heparin given to prevent clots, usually via IV route |
5. | the product of stroke volume and peripheral resistance |
6. | Chest pain or discomfort connected with cardiovascular occlusions or spasms |
7. | BP over 140/90, patient under 65 |
8. | Diet, lifestyle, activity, medications |
13. | occlusion or blockage of bloodflow leads to tissue damage |
14. | no known cause |
16. | Left sided heart failure effects |
17. | Thiazide diuretic |
18. | Enoxaparin and Dalteparin |
21. | protein released by brain to increase diuresis with increased sodium levels |
27. | Stiffened and fibrotic scarring leads to difficulty filling, shape changes |
28. | primary assessment of fluid balance in CHF; taken same time daily with same equipment; no increase is good. |
29. | Age, race, genetics, gender |
30. | MVR |
33. | Ring surrounding valve |
35. | VTE mechanical prophylaxis |
36. | resistance left ventricle has to overcome to circulate (peripheral resistance) |
38. | blood remains in artery, possibly between injured layers causing bulge |
39. | inflammation of sac that contains heart |
42. | volume of blood in ventricles at end of diastole |
44. | Ballooning of leaflet into chamber beyond or behind causing regurgitation of flow |
46. | reddish-blue discoloration of extremities; related to PAD |
51. | Antidote for warfarin |
52. | Sticky, spongy, fatty cholesterol |
57. | congestive heart failure |